Package 27854-555-01

{"route": ["ORAL"], "spl_id": "1318469f-79ca-4092-8617-e803250c4266", "openfda": {"unii": ["9TN87S3A3C"], "rxcui": ["849574"], "spl_set_id": ["a44b8a82-251d-d5e8-e053-2a95a90a72f7"], "manufacturer_name": ["Belmora LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (27854-555-01)  / 24 TABLET in 1 BOTTLE", "package_ndc": "27854-555-01", "marketing_start_date": "20200914"}, {"sample": false, "description": "40 PACKET in 1 BOX (27854-555-02)  / 1 TABLET in 1 PACKET", "package_ndc": "27854-555-02", "marketing_start_date": "20200720"}], "brand_name": "Belmora Flanax", "product_id": "27854-555_1318469f-79ca-4092-8617-e803250c4266", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "27854-555", "generic_name": "Naproxen Sodium", "labeler_name": "Belmora LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Belmora Flanax", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA090545", "marketing_category": "ANDA", "marketing_start_date": "20200720", "listing_expiration_date": "20261231"}